CHEMED CORPORATION (NYSE:CHE) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders
|
(a)
|
On May 15, 2017, Chemed Corporation held its annual
meeting of shareholders. |
| (b) |
Shareholders voted on the matters set forth below:
|
who constitute the entire Board of Directors, were elected at the
meeting by the votes indicated:
| Nominee | For | Against | Abstain | |
| Kevin J. McNamara | 14,065,686 | 84,005 | 10,066 |
| Joel F. Gemunder | 13,302,912 | 844,882 | 11,963 |
| Patrick P. Grace | 13,362,343 | 784,859 | 12,555 |
| Thomas C. Hutton | 13,797,374 | 352,030 | 10,353 |
| Walter L. Krebs | 14,002,256 | 146,581 | 10,920 |
| Andrea R. Lindell | 14,077,050 | 71,792 | 10,915 |
| Thomas P. Rice | 14,084,108 | 64,143 | 11,506 |
| Donald E. Saunders | 13,615,980 | 532,664 | 11,113 |
| George J. Walsh III | 13,423,077 | 727,515 | 9,165 |
| Frank E. Wood | 13,954,199 | 193,641 | 11,917 |
the appointment of PricewaterhouseCoopers LLP by the Audit
Committee of the Board of Directors as the Companys independent
auditor for the year ending December 31, 2017, was approved with
the following votes:
| Voted |
Percent of Voted
|
|||
| For | 14,726,912 | 98.47% | ||
| Against | 220,112 | 1.47% |
| Abstain | 8,751 | 0.06% |
proposal to approve, on a non-binding basis, the Companys
executive compensation program, was approved with the following
votes:
| Voted | Percent of Voted | |||
| For | 13,709,943 | 96.82% |
| Against | 394,704 | 2.79 % |
| Abstain | 55,110 | 0.39% |
| Broker non-votes | 796,018 | – |
Compensation. The proposal to approve, on a non-binding
basis, the frequency of shareholder advisory votes on executive
compensation, resulted in the following votes:
|
For:
|
|||
|
1 YR
|
12,252,374
|
||
|
2 YR
|
28,462
|
||
|
3 YR
|
1,812,663
|
||
|
Abstain
|
66,258
|
||
| Broker non-votes | 796,018 |
Companys Bylaws to allow holders of 10% of Chemed Corporation
capital stock to call Special Meetings of shareholders, was
disapproved with the following votes:
| Voted | Percent of Voted | |||
| For | 5,579,965 | 39.41% |
| Against | 8,556,620 | 60.43% |
| Abstain | 23,172 | 0.16% |
| Broker non-votes | 796,018 | – |
| (c) |
Following the vote on frequency of shareholder advisory
votes on executive compensation, the Board of Directors decided to include a shareholder vote on executive compensation in the Companys proxy materials each year until the next vote on frequency of shareholder advisory votes. |
About CHEMED CORPORATION (NYSE:CHE)
Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS segment provides hospice care to Medicare beneficiaries receiving their non-hospice healthcare services from health maintenance organizations (HMOs) under Medicare risk contracts. The Company and its subsidiaries also own training manuals, cost information, patient information and software source codes. A portion of its VITAS business is operated in the state of Florida. The Company’s Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers. CHEMED CORPORATION (NYSE:CHE) Recent Trading Information
CHEMED CORPORATION (NYSE:CHE) closed its last trading session down -1.95 at 200.31 with 67,776 shares trading hands.